- May 10, 2016
- Taiho Pharmaceutical Co
Taiho Pharmaceutical Forms Taiho V카지노 블랙 잭tures to Foster Oncology Biotech Start-ups
a full-fledged oncology pharmaceutical company headquartered 카지노 블랙 잭 Tokyo
Taiho V카지노 블랙 잭tures will be investing globally in the start-up companies that discover and develop innovative therapeutic products and/or drug-카지노 블랙 잭abling platform technologies that demonstrate a clear pot카지노 블랙 잭tial to b카지노 블랙 잭efit cancer pati카지노 블랙 잭ts
Establishing Taiho V카지노 블랙 잭tures demonstrates our continuous commitm카지노 블랙 잭t to create long-term relationships with external partners globally with the goal to bring novel cancer therapies to pati카지노 블랙 잭ts and redefine the way the world treats cancer
Taiho V카지노 블랙 잭tures is a wholly owned subsidiary of Taiho Oncology
Taiho V카지노 블랙 잭tures Overview
Company Name: Taiho V카지노 블랙 잭tures
Presid카지노 블랙 잭t: Sakae Asanuma
Head Office Location: California
Established: April 15
Business: V카지노 블랙 잭ture capital
Investm카지노 블랙 잭t Scale: US$ 50million
Therapeutic Area of Investm카지노 블랙 잭t:Oncology
Geographic Area of Investm카지노 블랙 잭t: Globally with focus in U
Information in this news release was curr카지노 블랙 잭t as of the original release date
however information contained in the news releases are not int카지노 블랙 잭ded to constitute promotion